Logo

American Heart Association

  40
  0


Final ID:

Leveraging polygenic risk scores in HCM: Is more the merrier?

  • Ware, James  ( Imperial College London , London , United Kingdom )
  • Author Disclosures:
    James Ware: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bristol Myers-Squibb:Active (exists now) ; Ownership Interest:Saturnus Bio:Active (exists now) ; Advisor:Health Lumen; Tenaya Therapeutics; Solid Biosciences; Saturnus Bio:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Impact of Genetics on the Family – from Mendelian to Polygenic

Friday, 11/07/2025 , 09:30AM - 11:00AM

Cardiovascular Seminar

More abstracts from these authors:
Can deep clinical phenotyping resolve uncertainty for my patient?

Arbustini Eloisa, Ware James, Elliott Perry, Day Sharlene

Artificial Intelligence-Enabled Electrocardiography For The Prediction of Future Type 2 Diabetes Mellitus

Pastika Libor, Peters Nicholas, Kramer Daniel, Waks Jonathan, Sau Arunashis, Ng Fu Siong, Patlatzoglou Konstantinos, Sieliwonczyk Ewa, Barker Joseph, Zeidaabadi Boroumand, Mcgurk Kathryn, Khan Sadia, Mandic Danilo, Ware James

You have to be authorized to contact abstract author. Please, Login
Not Available